Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience

por Miller, Aaron E.
Publicado 2017

Perceptions of risk and adherence to care in MS patients during the COVID-19 pandemic: A cross-sectional study

por Zhang, Yinan, Staker, Erin, Cutter, Gary, Krieger, Stephen, Miller, Aaron E
Publicado 2021

Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials

por Comi, Giancarlo, Miller, Aaron E, Benamor, Myriam, Truffinet, Philippe, Poole, Elizabeth M, Freedman, Mark S
Publicado 2019

Effects of teriflunomide treatment on cognitive performance and brain volume in patients with relapsing multiple sclerosis: Post hoc analysis of the TEMSO core and extension studie...

por Sprenger, Till, Kappos, Ludwig, Sormani, Maria Pia, Miller, Aaron E, Poole, Elizabeth M, Cavalier, Steven, Wuerfel, Jens
Publicado 2022

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies

por Freedman, Mark S, Wolinsky, Jerry S, Comi, Giancarlo, Kappos, Ludwig, Olsson, Tomas P, Miller, Aaron E, Thangavelu, Karthinathan, Benamor, Myriam, Truffinet, Philippe, O’Connor, Paul W
Publicado 2017

A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment

por Cohen, Jeffrey A, Cameron, Michelle H, Goldman, Myla D, Goodman, Andrew D, Miller, Aaron E, Rollins, Anne, Llorens, Lily, Patni, Rajiv, Elfont, Robert, Johnson, Reed
Publicado 2021

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis

por Miller, Aaron E, O’Connor, Paul, Wolinsky, Jerry S, Confavreux, Christian, Kappos, Ludwig, Olsson, Tomas P, Truffinet, Philippe, Wang, Lin, D’Castro, Laura, Comi, Giancarlo, Freedman, Mark S
Publicado 2012

Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study

por Miller, Aaron E., Macdonell, Richard, Comi, Giancarlo, Freedman, Mark S., Kappos, Ludwig, Mäurer, Mathias, Olsson, Tomas P., Wolinsky, Jerry S., Bozzi, Sylvie, Dive-Pouletty, Catherine, O’Connor, Paul W.
Publicado 2014

Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use

por O’Connor, Paul W., Lublin, Fred D., Wolinsky, Jerry S., Confavreux, Christian, Comi, Giancarlo, Freedman, Mark S., Olsson, Tomas P., Miller, Aaron E., Dive-Pouletty, Catherine, Bégo-Le-Bagousse, Gaëlle, Kappos, Ludwig
Publicado 2013

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study

por Bar-Or, Amit, Grove, Richard A., Austin, Daren J., Tolson, Jerry M., VanMeter, Susan A., Lewis, Eric W., Derosier, Frederick J., Lopez, Monica C., Kavanagh, Sarah T., Miller, Aaron E., Sorensen, Per S.
Publicado 2018

Sleep disturbance and memory dysfunction in early multiple sclerosis

por Sumowski, James F., Horng, Sam, Brandstadter, Rachel, Krieger, Stephen, Leavitt, Victoria M., Katz Sand, Ilana, Fabian, Michelle, Klineova, Sylvia, Graney, Robin, Riley, Claire S., Lublin, Fred D., Miller, Aaron E., Varga, Andrew W.
Publicado 2021

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study

por O'Connor, Paul, Comi, Giancarlo, Freedman, Mark S., Miller, Aaron E., Kappos, Ludwig, Bouchard, Jean-Pierre, Lebrun-Frenay, Christine, Mares, Jan, Benamor, Myriam, Thangavelu, Karthinathan, Liang, Jinjun, Truffinet, Philippe, Lawson, Victoria J., Wolinsky, Jerry S.
Publicado 2016

Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC)

por Zivadinov, Robert, Cookfair, Diane L., Krupp, Lauren, Miller, Aaron E., Lava, Neil, Coyle, Patricia K., Goodman, Andrew D., Jubelt, Burk, Lenihan, Michael, Herbert, Joseph, Gottesman, Malcolm, Snyder, David H., Apatoff, Brian R., Teter, Barbara E., Perel, Allan B., Munschauer, Frederick, Weinstock-Guttman, Bianca
Publicado 2016

Defining the clinical course of multiple sclerosis: The 2013 revisions

por Lublin, Fred D., Reingold, Stephen C., Cohen, Jeffrey A., Cutter, Gary R., Sørensen, Per Soelberg, Thompson, Alan J., Wolinsky, Jerry S., Balcer, Laura J., Banwell, Brenda, Barkhof, Frederik, Bebo, Bruce, Calabresi, Peter A., Clanet, Michel, Comi, Giancarlo, Fox, Robert J., Freedman, Mark S., Goodman, Andrew D., Inglese, Matilde, Kappos, Ludwig, Kieseier, Bernd C., Lincoln, John A., Lubetzki, Catherine, Miller, Aaron E., Montalban, Xavier, O'Connor, Paul W., Petkau, John, Pozzilli, Carlo, Rudick, Richard A., Sormani, Maria Pia, Stüve, Olaf, Waubant, Emmanuelle, Polman, Chris H.
Publicado 2014